REGENTIS BIOMATERIALS LTD/IS RGNT
$4.03
-11.8% 52w: $1.28 – $9.40
Latest 13F among current holders filed 1 month ago (May 14, 2026)
Price — last 12 months
research preview data1.285.349.40
Dec 4, 2025 Jul 2, 2026
Institutional holders
3
+0 QoQ
13F value
$1.7M
-10.9% QoQ
Smart-money holders
2
signal tier ≥ 2
New smart buyers
1
Q1 2026
Institutional value by quarter
Number of holders
Who owns RGNT?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| AIGH Capital Management LLC ★2 | Fundamental concentrated | 300.0K | $917K | 0.2% | New |
| Rosalind Advisors, Inc. ★2 | Fundamental concentrated | 251.5K | $768K | 0.3% | Held |
| UBS Group AG | Bank broker | 334 | $1K | 0.0% | New |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding RGNT
More healthcare stocks held by institutions